Schrodinger Cash Flow from Investing Activities 2019-2025 | SDGR
Schrodinger cash flow from investing activities from 2019 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Schrodinger Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $149 |
| 2023 | $193 |
| 2022 | $90 |
| 2021 | $-17 |
| 2020 | $-382 |
| 2019 | $-54 |
| 2018 | $11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.573B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.399B | 58.01 |
| Hims & Hers Health (HIMS) | United States | $11.729B | 121.86 |
| Tempus AI (TEM) | United States | $9.423B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.541B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.078B | 63.71 |
| Privia Health (PRVA) | United States | $2.749B | 187.92 |
| Enovis (ENOV) | United States | $1.831B | 10.21 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Phreesia (PHR) | United States | $1.454B | 0.00 |
| Omnicell (OMCL) | United States | $1.397B | 24.65 |
| Azenta (AZTA) | United States | $1.251B | 58.15 |
| 10x Genomics (TXG) | United States | $1.149B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.627B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.591B | 0.00 |
| Talkspace (TALK) | United States | $0.549B | 164.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.67 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Pulmonx (LUNG) | United States | $0.129B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 3.42 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |